SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-078750
Filing Date
2014-11-10
Accepted
2014-11-10 10:33:07
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-19766_110q.htm 10-Q 955623
2 EX-31.1.1 a14-19766_1ex31d1d1.htm EX-31.1.1 17816
3 EX-31.2.1 a14-19766_1ex31d2d1.htm EX-31.2.1 17740
4 EX-32.1 a14-19766_1ex32d1.htm EX-32.1 6866
  Complete submission text file 0001104659-14-078750.txt   8745331

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT osir-20140930.xml EX-101.INS 1212423
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT osir-20140930.xsd EX-101.SCH 87795
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT osir-20140930_cal.xml EX-101.CAL 76034
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT osir-20140930_def.xml EX-101.DEF 345486
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT osir-20140930_lab.xml EX-101.LAB 1388252
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT osir-20140930_pre.xml EX-101.PRE 640790
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32966 | Film No.: 141207057
SIC: 2836 Biological Products, (No Diagnostic Substances)